Newsfeeds Archive - Page 64 of 167

4 minute read

News

Nasdaq To Organize Its Business Units Into Market Platforms, Capital Access Platforms And Anti-Financial Crime Units

September 28, 7:04 AM

Organizes Nasdaq's business units into three divisions: Market Platforms, Capital Access Platforms, and Anti-Financial Crime Positions Nasdaq to better deliver for clients and scale for the future NEW YORK,

NDAQ

1 minute read

Cognyte Software Q2 EPS $(0.04) Beats $(0.17) Estimate, Sales $81.30M Miss $92.49M Estimate

By Bill Haddad

September 28, 7:01 AM

Cognyte Software (NASDAQ:CGNT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.17) by 76.47 percent. This is a 123.53 percent decrease over earnings of $0.17 per share from

CGNT

7 minute read

TCR2 Therapeutics Announces Topline Results From Phase 1 Portion Of gavo-cel Phase 1/2 Trial; Showed ‘Consistent tumor regression in 28 of 30 (93%) evaluable patients with disease control rate of 77%’

By Bill Haddad

September 28, 6:46 AM

- Completed Phase 1 clinical trial establishes gavo-cel monotherapy as the first anti-mesothelin cell therapy to demonstrate tolerability and clinical benefit - Second RECIST partial response in ovarian cancer supports

TCRR

2 minute read

Ocugen Announces Agreement With Washington University In St. Louis For Commercialization Of Intranasal COVID-19 Vaccine In U.S., Europe And Japan

By Bill Haddad

September 28, 6:32 AM

Ocugen's intranasal candidate is one of the world's most advanced intranasal COVID-19 vaccines Intranasal vaccine is designed to curb virus transmission and confer protective immunity MALVERN, Pa., Sept. 28,

OCGN

1 minute read

Thor Industries Q4 EPS $5.15 Beats $3.84 Estimate, Sales $3.82B Beat $3.68B Estimate

By Bill Haddad

September 28, 6:30 AM

Thor Industries (NYSE:THO) reported quarterly earnings of $5.15 per share which beat the analyst consensus estimate of $3.84 by 34.11 percent. This is a 25 percent increase over earnings of $4.12 per share from the same

THO

2 minute read

Hepsiburada Q2 Revenue TRY 2,985.2M, Down 6.2% YoY; Orders Up 8.0%, Active Customers Up 17.5%

By Bill Haddad

September 28, 6:16 AM

Second Quarter 2022 Financial and Operational Highlights (All financial figures are restated pursuant to IAS 29 unless otherwise indicated) Gross merchandise value (GMV) decreased by 9.7% to TRY

HEPS

1 minute read

General

MIND Technology Completes Demonstration Of Sea Serpent Low-Cost Anti-Submarine Warfare System

By Bill Haddad

September 28, 6:05 AM

THE WOODLANDS, Texas, Sept. 27, 2022 /PRNewswire/ -- MIND Technology, Inc. ("MIND" or the "Company") (NASDAQ:MIND) announced today that it has completed a successful demonstration of its Sea

MIND

4 minute read

PepGen Reports Data From Phase 1 Trial Of PGN-EDO51 For Treatment Of Duchenne Muscular Dystrophy

By Bill Haddad

September 28, 6:03 AM

PGN-EDO51 exhibited the highest levels of oligonucleotide delivery and exon skipping in a clinical study following a single dose when compared to publicly available clinical data for other exon 51 skipping

PEPG

1 minute read

Smart Share Global Limited Announces 12-Month Extension of Share Repurchase Program

By Bill Haddad

September 28, 6:01 AM

SHANGHAI, China, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Smart Share Global Limited ("Energy Monster" or the "Company"), a consumer tech company providing mobile device charging service, today announced